This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2tld

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2tld.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:2tld.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2tld| PDB=2tld | SCENE= }}
{{STRUCTURE_2tld| PDB=2tld | SCENE= }}
-
'''CRYSTAL STRUCTURE OF AN ENGINEERED SUBTILISIN INHIBITOR COMPLEXED WITH BOVINE TRYPSIN'''
+
===CRYSTAL STRUCTURE OF AN ENGINEERED SUBTILISIN INHIBITOR COMPLEXED WITH BOVINE TRYPSIN===
-
==Overview==
+
<!--
-
Proteinase specificity of a proteinaceous inhibitor of subtilisin (SSI; Streptomyces subtilisin inhibitor) can be altered so as to strongly inhibit trypsin simply by replacing P1 methionine with lysine (with or without concomitant change of the P4 residue) through site-directed mutagenesis. Now the crystal structure of one such engineered SSI (P1 methionine converted to lysine and P4 methionine converted to glycine) complexed with bovine trypsin has been solved at 2.6 A resolution and refined to a crystallographic R factor of 0.173. Comparing this structure with the previously established structure of the native SSI complexed with subtilisin BPN', it was found that (i) P1 lysine of the mutant SSI is accommodated in the S1 pocket of trypsin as usual, and (ii) upon complex formation, considerable conformation change occurs to the reactive site loop of the mutant SSI. Thus, in this case, flexibility of the reactive site loop seems important for successfully changing the proteinase specificity through mere replacement of the P1 residue.
+
The line below this paragraph, {{ABSTRACT_PUBMED_1584773}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 1584773 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_1584773}}
==About this Structure==
==About this Structure==
Line 27: Line 31:
[[Category: Nonaka, T.]]
[[Category: Nonaka, T.]]
[[Category: Takeuchi, Y.]]
[[Category: Takeuchi, Y.]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 17:24:20 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 00:26:03 2008''

Revision as of 21:26, 27 July 2008

Image:2tld.png

Template:STRUCTURE 2tld

CRYSTAL STRUCTURE OF AN ENGINEERED SUBTILISIN INHIBITOR COMPLEXED WITH BOVINE TRYPSIN

Template:ABSTRACT PUBMED 1584773

About this Structure

2TLD is a Protein complex structure of sequences from Bos taurus. Full crystallographic information is available from OCA.

Reference

Crystal structure of an engineered subtilisin inhibitor complexed with bovine trypsin., Takeuchi Y, Nonaka T, Nakamura KT, Kojima S, Miura K, Mitsui Y, Proc Natl Acad Sci U S A. 1992 May 15;89(10):4407-11. PMID:1584773

Page seeded by OCA on Mon Jul 28 00:26:03 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2tld"
Personal tools